IRCT20190626044013N2
Recruiting
Phase 2
Evaluation of administration of Dexmedetomidine on recovery conditions in mentally-disabled adults, candidate for dental treatment under general aneasthesia
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •mentally disabled
- •without systemic diseases or physical disabilities
- •need dental treatment under general aneasthesia
Exclusion Criteria
- •unwilling to participate in the study
- •using tranquillizers, anticonvulsive, antidepressants, antipsychotic drugs
- •allergic to soy or eggs
- •hepatic diseases
- •Morbidly obese (BMI\=40\)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Evaluation of the efficacy of dexmedetomidine as an anesthetic and effects of spinal cord monitoringSpinal cord tumors, spinal disordersJPRN-UMIN000009044iigata University Medical and Dental Hospital, Anesthesiology10
Recruiting
Phase 3
effect of dexmedetomidine in inducing and maintaining cardiac surgery anesthesiaIRCT20240624062233N1Gorgan University of Medical Sciences70
Completed
Phase 3
Evaluation of dexmedetomidine in reducing postoperative ocular paiIRCT20200503047291N1Mashhad University of Medical Sciences30
Completed
Phase 2
The evaluation of the effect of dexmedetomidine added to local infiltration of bupivacaine on post-operative pain of pediatric inguinal herniorraphy.Inguinal hernia.Inguinal herniaIRCT2016060314372N8Vice Chancellor for Research, Shiraz University of Medical Sciences60
Recruiting
Phase 3
Evaluation of the effectiveness of dexmedetomidineine sedation of COVID-19 critically ill patientsIRCT20110425006280N13Vice President of Research Guilan university of medical sciences60